Comparative Effectiveness of mRNA and Inactivated Whole-Virus Vaccines Against Coronavirus Disease 2019 Infection and Severe Disease in Singapore.

M Premikha,Calvin J Chiew,Wycliffe E Wei,Yee Sin Leo,Benjamin Ong,David Chien Lye,Vernon J Lee,Kelvin Bryan Tan

SSRN Electronic Journal（2022）

引用 37|浏览0

暂无评分

摘要

Compared with individuals vaccinated with Pfizer-BioNTech/Comirnaty, recipients of Sinovac-CoronaVac and Sinopharm were 2.37 (95% CI, 2.29-2.46) and 1.62 (95% CI, 1.43-1.85) times more likely to be infected with coronavirus disease 19, respectively, while individuals vaccinated with Moderna were 0.42 (95% CI, 0.25-0.70) times less likely to develop severe disease.

查看译文

关键词

COVID-19, SARS-CoV-2, vaccines, mRNA vaccine, inactivated vaccine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要